Eastman Kodak reported increases in fourth quarter and year-end (end-December) revenue for its Health Imaging group. For the quarter, sales were $571 million, up 29% compared with 1998’s $442 million, which Kodak attributed to its 1998 acquisition
Eastman Kodak reported increases in fourth quarter and year-end (end-December) revenue for its Health Imaging group. For the quarter, sales were $571 million, up 29% compared with 1998s $442 million, which Kodak attributed to its 1998 acquisition of Imations medical imaging business in a deal worth $520 million (SCAN 8/19/98). For the year, revenues climbed 39% to $2.1 billion from the previous years $1.5 billion.
The Rochester, NY-companys Health Imaging Group also saw dramatic increases in earnings from operations, which rose 232% for the quarter from $38 million in 1998 to $126 million. For the year, the group posted operating earnings of $470 million, up 46% from 1998s $321 million.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.